Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma
2006 ◽
Vol 103
(3)
◽
pp. 1054-1062
◽
Keyword(s):
2016 ◽
Vol 13
(4)
◽
pp. 528-533
◽
1989 ◽
Vol 264
(29)
◽
pp. 17551-17558
◽
1990 ◽
Vol 265
(32)
◽
pp. 19980-19989
1997 ◽
Vol 38
(12)
◽
pp. 2465-2472
◽
1988 ◽
Vol 263
(31)
◽
pp. 16379-16387
◽
Keyword(s):